RAMZORDiagnostic

Company Overview

Snapshot

Founded in October 2019 by Boris Melnik and Ilya Mezhibovsky, RAMZORDiagnostic operates with 1–10 employees. The company ceased operations in April 2022.

Business overview

RAMZORDiagnostic specializes in developing a real-time noninvasive tissue examination system designed for early melanoma detection. The core technology utilizes spectral signatures to map metabolic activity in the skin, aiming to provide an early warning before the disease progresses. The company's algorithm for early detection was developed through multi-year research and is based on understanding changes in the optical properties of the skin correlating with melanoma growth. RAMZORDiagnostic operates within the Health Tech & Life Sciences sector, specifically targeting Digital Healthcare and Digital Medical Diagnostics markets, serving hospitals, clinics, and doctors.

Company Intelligence Q&A

What is RAMZORDiagnostic's primary focus?

RAMZORDiagnostic is focused on developing a noninvasive early melanoma detection system that uses spectral signatures to map metabolic activity in the skin.

When was RAMZORDiagnostic founded?

RAMZORDiagnostic was founded in October 2019.

What is the operational status of RAMZORDiagnostic?

RAMZORDiagnostic ceased to operate in April 2022.

Who are the founders of RAMZORDiagnostic?

The company was founded by Boris Melnik and Ilya Mezhibovsky.

What technology underpins RAMZORDiagnostic's detection system?

The detection system is based on an algorithm developed from multi-year research, understanding changes in the optical properties of the skin that correlate with melanoma growth.